Seres Therapeutics

Microbiome Report for Week Ending 2/9/19
Microbiome Report for Week Ending 2/9/19
CP Wire
microbiome
Seres Therapeutics
Kallyope
Flag link:
Microbiome Report for Week Ending 2/9/19
microbiome
Seres Therapeutics
Kallyope
Flag link:
New CEO axes 30% of Seres’ workforce to refocus on ‘high priority’ late-stage efforts
New CEO axes 30% of Seres’ workforce to refocus on ‘high priority’ late-stage efforts
Fierce Biotech
Seres Therapeutics
layoffs
Flag link:
Microbiome Report for Week Ending 1/19/19
Microbiome Report for Week Ending 1/19/19
CP Wire
microbiome
Seres Therapeutics
Synlogic
Kaleido Biosciences
IPOs
Flag link:
Microbiome Report for Week Ending 1/19/19
microbiome
Seres Therapeutics
Synlogic
Kaleido Biosciences
Flag link:
Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer
Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer
CP Wire
Seres Therapeutics
microbiome
Flag link:
Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer
Seres Therapeutics
Flag link:
Microbiome Report for Week Ending 10/6/18
Microbiome Report for Week Ending 10/6/18
CP Wire
Rebiotix
Vedanta Biosciences
Seres Therapeutics
LNC Therapeutics
Synlogic
Flag link:
Microbiome Report for Week Ending 10/6/18
Rebiotix
Vedanta Biosciences
Seres Therapeutics
LNC Therapeutics
Synlogic
Flag link:
Microbiome Focused Seres Therapeutics Adds Experienced Biopharmaceutical Financial Leader to Board of Directors
Microbiome Focused Seres Therapeutics Adds Experienced Biopharmaceutical Financial Leader to Board of Directors
CP WIre
Seres Therapeutics
microbiome
Flag link:
Microbiome Focused Seres Therapeutics Adds Experienced Biopharmaceutical Financial Leader to Board of Directors
Seres Therapeutics
Flag link:
Pharma moves beyond Seres hangover in microbiome space
Pharma moves beyond Seres hangover in microbiome space
Biopharma Dive
Seres Therapeutics
microbiome
Flag link:
These five biotech CEOs earned big bucks even as their companies tanked
These five biotech CEOs earned big bucks even as their companies tanked
Stat
biotech
executive pay
Seres Therapeutics
Pacira
Ophthotech
Cempra
Endo International
Flag link:
Seres doubles down on a microbiome do-over as the FDA clears a make-or-break study
Seres doubles down on a microbiome do-over as the FDA clears a make-or-break study
Endpoints
Seres Therapeutics
microbiome
FDA
clinical trials
SER-109
Flag link:
Microbiome work reignites after Seres' initial flame-out
Microbiome work reignites after Seres' initial flame-out
BioPharma Dive
Seres Therapeutics
microbiome
Flag link:
How biotech executives profit from legal insider trades
How biotech executives profit from legal insider trades
Stat
biotech
insider trading
Seres Therapeutics
Flag link:
Seres Therapeutics To Conduct First Clinical Trial Of Synthetic Microbiome Drug
Seres Therapeutics To Conduct First Clinical Trial Of Synthetic Microbiome Drug
Xtalks
Seres Therapeutics
clinical trials
SER-262
microbiome
Clostridium Difficile
Flag link:
9 Biotech Picks for 2016
9 Biotech Picks for 2016
Barron's
biotech
Adaptimmune
Dermira
FibroGen
Incyte
Intra-Cellular Therapies
Seres Therapeutics
Ophthotech
Neurocrine Biosciences
Paratek
Flag link:
Could These Hot 2015 Biotech IPOs Be 2016 Buyout Targets?
Could These Hot 2015 Biotech IPOs Be 2016 Buyout Targets?
24/7 Wall St
M&A
biotech
IPOs
Seres Therapeutics
Collegium Pharmaceutical
Spark Therapeutics
Flag link:
IPO Preview: Seres Therapeutics
IPO Preview: Seres Therapeutics
Seeking Alpha
IPOs
Seres Therapeutics
microbiome
Flag link:

Pages